Study to Assess the Efficacy of Baloxavir Marboxil Versus Placebo to Reduce Onward Transmission of Influenza A or B in Households
Clinical trial NCT03969212 · COMPLETED
Trial details
- NCT number
- NCT03969212
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-10
- Primary completion
- 2024-05-10
- Enrollment
- 4138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.